Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clear cell papillary renal cell carcinoma: a review

N. Kuroda, C. Ohe, F. Kawakami, S. Mikami, M. Furuya, K. Matsuura, M. Moriyama, Y. Nagashima, M. Zhou, F. Petersson, JI. López, O. Hes, M. Michal, MB. Amin,

. 2014 ; 7 (11) : 7312-8. [pub] 20141015

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc17024254

The disease concept of clear cell (tubulo) papillary renal cell carcinoma (CCP-RCC) as a distinct subtype of renal cell carcinoma has been recently established. First described in the setting of end stage renal disease, this tumor type is more frequently recognized and encountered in a sporadic setting. In this article, we provide an overview of the recent understanding of this tumor. Macroscopically, tumors are well circumscribed with well-developed tumor capsule. Histologically, the tumor cells are cuboidal to low columnar cell with clear cytoplasm and papillary and tubulo-papillary configuration. Immunohistochemically, tumor cells generally show diffuse expression for cytokeratin 7, CA9 (cup-shaped pattern), HIF-1, GLUT-1 and high molecular weight cytokeratin, but negative for AMACR, RCC Ma and TFE3. CD10 is negative or focally positive in most tumors. Genetically, this tumor has no characteristics of clear cell RCC or papillary RCC. Prognostically, patients with CCP-RCC behave in an indolent fashion in all previously reported cases. In conclusion, although this tumor has been integrated into recent International Society of Urologic Pathology Classification of renal neoplasia, both aspects of disease concept and clinical behavior are yet to be fully elucidated. Further publications of large cohorts of patients will truly help understand the biologic potential and the molecular underpinnings of this tumor type.

000      
00000naa a2200000 a 4500
001      
bmc17024254
003      
CZ-PrNML
005      
20170906111050.0
007      
ta
008      
170720s2014 xxu f 000 0|eng||
009      
AR
035    __
$a (PubMed)25550767
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kuroda, Naoto $u Department of Diagnostic Pathology, Kochi Red Cross Hospital Kochi, Japan.
245    10
$a Clear cell papillary renal cell carcinoma: a review / $c N. Kuroda, C. Ohe, F. Kawakami, S. Mikami, M. Furuya, K. Matsuura, M. Moriyama, Y. Nagashima, M. Zhou, F. Petersson, JI. López, O. Hes, M. Michal, MB. Amin,
520    9_
$a The disease concept of clear cell (tubulo) papillary renal cell carcinoma (CCP-RCC) as a distinct subtype of renal cell carcinoma has been recently established. First described in the setting of end stage renal disease, this tumor type is more frequently recognized and encountered in a sporadic setting. In this article, we provide an overview of the recent understanding of this tumor. Macroscopically, tumors are well circumscribed with well-developed tumor capsule. Histologically, the tumor cells are cuboidal to low columnar cell with clear cytoplasm and papillary and tubulo-papillary configuration. Immunohistochemically, tumor cells generally show diffuse expression for cytokeratin 7, CA9 (cup-shaped pattern), HIF-1, GLUT-1 and high molecular weight cytokeratin, but negative for AMACR, RCC Ma and TFE3. CD10 is negative or focally positive in most tumors. Genetically, this tumor has no characteristics of clear cell RCC or papillary RCC. Prognostically, patients with CCP-RCC behave in an indolent fashion in all previously reported cases. In conclusion, although this tumor has been integrated into recent International Society of Urologic Pathology Classification of renal neoplasia, both aspects of disease concept and clinical behavior are yet to be fully elucidated. Further publications of large cohorts of patients will truly help understand the biologic potential and the molecular underpinnings of this tumor type.
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a papilární karcinom $x klasifikace $x patologie $7 D002291
650    _2
$a karcinom z renálních buněk $x klasifikace $x patologie $7 D002292
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a nádory ledvin $x klasifikace $x patologie $7 D007680
650    _2
$a prognóza $7 D011379
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Ohe, Chisato $u Department of Pathology, Kansai Medical University Hirakata Hospital Osaka, Japan.
700    1_
$a Kawakami, Fumi $u Department of Diagnostic Pathology, Kobe University Hospital Kobe, Japan.
700    1_
$a Mikami, Shuji $u Division of Diagnostic Pathology, Keio University Hospital Tokyo, Japan.
700    1_
$a Furuya, Mitsuko $u Department of Molecular Pathology, Yokohama City University Graduate School of Medicine Yokohama, Japan.
700    1_
$a Matsuura, Keiko $u Department of Molecular Pathology, Oita University Oita, Japan.
700    1_
$a Moriyama, Masatsugu $u Department of Molecular Pathology, Oita University Oita, Japan.
700    1_
$a Nagashima, Yoji $u Division of Diagnostic Pathology, Tokyo Women's Medical University Hospital Tokyo, Japan.
700    1_
$a Zhou, Ming $u Department of Pathology, New York Medical Center NY, USA.
700    1_
$a Petersson, Fredrik $u Department of Pathology, National University Hospital System Singapore, Singapore.
700    1_
$a López, José I $u Department of Pathology, Cruces University Hospital, BioCruces Health Research Institute, University of the Basque Country (EHU/UPV) Barakaldo, Bizkaia, Spain.
700    1_
$a Hes, Ondrej $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzen Pilsen, Czech Republic.
700    1_
$a Michal, Michal $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzen Pilsen, Czech Republic.
700    1_
$a Amin, Mahul B $u Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center Los Angeles, CA, USA. $7 gn_A_00005584
773    0_
$w MED00165429 $t International journal of clinical and experimental pathology $x 1936-2625 $g Roč. 7, č. 11 (2014), s. 7312-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25550767 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170906111648 $b ABA008
999    __
$a ok $b bmc $g 1239935 $s 985167
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 7 $c 11 $d 7312-8 $e 20141015 $i 1936-2625 $m International journal of clinical and experimental pathology $n Int. j. clin. exp. pathol. $x MED00165429
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace